PFIZER's THREE-PRONGED OTC GROWTH STRATEGY
This article was originally published in The Tan Sheet
Executive Summary
PFIZER's THREE-PRONGED OTC GROWTH STRATEGY includes capitalizing on current brands through line extensions, acquisitions and Rx-to-OTC switches, Exec VP and Chief Financial Officer Hank McKinnell told a meeting of securities analysts Feb. 8 in New York City. "The foundation for future growth is being laid," McKinnell said, "with the initiation of a number of complementary strategies," such as "looking to further capitalize on the strong brand identification of leading products in their category," including Desitin and Unisom.